Micro-X Limited (ASX:MX1)

Market Cap	38.37M -42.5%
Revenue (ttm)	15.09M +15.6%
Net Income	-9.88M
EPS	-0.01
Shares Out	752.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	345,657
Open	0.0510
Previous Close	0.0540
Day's Range	0.0510 - 0.0540
52-Week Range	0.0140 - 0.1200
Beta	-0.93
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 23, 2026

About Micro-X

Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard am...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MX1

Financial Performance

In fiscal year 2026, Micro-X's revenue was 15.09 million, an increase of 15.58% compared to the previous year's 13.05 million. Losses were -9.88 million, -28.92% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 7, 2026

Data Sources Report a data error